Cephalon To Pay $125M To Settle Provigil Antitrust Litigation
Cephalon Inc. has reached a $125 million settlement with 48 states, including New York, New Jersey, Florida, Pennsylvania and Texas, to resolve allegations it paid generic-drug makers to delay launching their...To view the full article, register now.
Already a subscriber? Click here to view full article